Cowen Inc’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cowen Inc’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-40,000	Closed	-$49K	–	546
2019 Q1	$49K	Buy	+40,000	New	+$3.4M	0.01%	273
2018 Q4	–	Sell	-40,000	Closed	-$6K	–	521
2018 Q3	$6K	Sell	40,000 -18,100	-31%	-$1.75M	﹤0.01%	471
2018 Q2	$5.53M	Buy	+58,100	New	+$5.34M	0.23%	76
2016 Q2	–	Sell	-5,500	Closed	-$284K	–	297
2016 Q1	$284K	Buy	+5,500	New	+$286K	0.01%	207

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Cowen Inc's XBI Position: Q2 2019 in Review

Cowen Inc sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2019, closing a stake of 3,600 shares — an estimated $307K sold.

Cowen Inc first reported a position in XBI in Q1 2019 and held it in 1 quarter. The position peaked at $326K in Q1 2019. 424 funds tracked by Wall St. Rank hold XBI as of Q2 2019.

Cowen Inc reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2019 after selling out during the quarter.
Cowen Inc sold 3,600 State Street SPDR S&P Biotech ETF shares in Q2 2019, an estimated $307K.
Cowen Inc first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 1 quarter.
Cowen Inc's State Street SPDR S&P Biotech ETF position peaked at $326K in Q1 2019.
424 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.